CLOV stock · LPCN stock

CLOV vs LPCN · rev $1.37B vs rev $11.2M

Clover Health Investments Corp (CLOV) versus Lipocine Inc (LPCN) — a side-by-side from cached financials, not a winner call.

Clover Health Investments Corp (CLOV) is a healthcare plans company listed on US.

Lipocine Inc (LPCN) is a biotechnology company listed on NASDAQ.

Latest reported CLOV revenue for 2024-12-31 was $1.37B. Net income was -$43.0M. Revenue was up 8.8% from 2023-12-31 to 2024-12-31. CLOV currently screens at market cap $1.55B.

Latest reported LPCN revenue for 2024-12-31 was $11.2M. Net income was $8.4K. Revenue was up 492.8% from 2023-12-31 to 2024-12-31. LPCN currently screens at market cap $19.3M.

CLOV currently screens at market cap $1.55B. LPCN currently screens at market cap $19.3M.

Not investment advice. Open the CLOV and LPCN stock pages for the full models.

Not investment advice.

Popular Stock Comparisons